Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $19.00.
A number of equities analysts have recently issued reports on CCAP shares. Bank of America cut their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating for the company in a report on Thursday, August 15th. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 14th. Finally, LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a "buy" rating and a $20.00 price objective for the company.
View Our Latest Report on CCAP
Institutional Investors Weigh In On Crescent Capital BDC
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Sun Life Financial Inc. grew its holdings in Crescent Capital BDC by 8.1% in the second quarter. Sun Life Financial Inc. now owns 1,843,766 shares of the company's stock worth $34,626,000 after purchasing an additional 137,684 shares during the period. Deerfield Management Company L.P. Series C purchased a new stake in shares of Crescent Capital BDC in the 2nd quarter worth approximately $1,021,000. Hennion & Walsh Asset Management Inc. increased its position in Crescent Capital BDC by 182.3% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 49,482 shares of the company's stock valued at $929,000 after buying an additional 31,952 shares in the last quarter. Millennium Management LLC raised its stake in Crescent Capital BDC by 31.9% during the second quarter. Millennium Management LLC now owns 268,097 shares of the company's stock valued at $5,035,000 after buying an additional 64,902 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in Crescent Capital BDC in the second quarter worth $767,000. 49.46% of the stock is owned by hedge funds and other institutional investors.
Crescent Capital BDC Price Performance
Shares of CCAP stock traded down $0.11 during trading hours on Friday, reaching $18.39. The stock had a trading volume of 71,272 shares, compared to its average volume of 132,821. The stock's fifty day simple moving average is $18.42 and its 200 day simple moving average is $18.29. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $681.57 million, a PE ratio of 6.54 and a beta of 0.81. Crescent Capital BDC has a 12 month low of $15.03 and a 12 month high of $19.63.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The company had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. During the same quarter last year, the company earned $0.56 earnings per share. On average, equities research analysts predict that Crescent Capital BDC will post 2.35 EPS for the current year.
Crescent Capital BDC Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th were issued a $0.42 dividend. The ex-dividend date was Monday, September 30th. This is a positive change from Crescent Capital BDC's previous quarterly dividend of $0.09. This represents a $1.68 annualized dividend and a yield of 9.14%. Crescent Capital BDC's dividend payout ratio (DPR) is 59.79%.
Crescent Capital BDC Company Profile
(
Get Free ReportCrescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Articles
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.